Child-Pugh score is a foundational clinical scoring system designed to assess the prognosis, surgical risk, and residual functional reserve of patients suffering from chronic liver disease and cirrhosis 1,2. Originally developed by Child and Turcotte in 1964 to stratify patients undergoing surgery for esophageal variceal bleeding, it was later modified by Pugh et al. in 1973 by substituting nutritional status with the prothrombin time (or International Normalized Ratio) 1,4. By quantifying clinical markers of liver synthetic dysfunction and portal hypertension, the score stratifies patients into three distinct classes (A, B, and C), guiding clinical management, medication dosage adjustments, and decisions regarding liver transplantation evaluation 1,2,3.
Etiology & Risk Factors
- Chronic Viral Hepatitis: Persistent infection with Hepatitis B virus (HBV) or Hepatitis C virus (HCV) leading to chronic necroinflammation, fibrogenesis, and eventual micronodular or macronodular cirrhosis 1,4.
- Alcohol-Associated Liver Disease (ALD): Chronic, heavy ethanol consumption causing direct hepatotoxicity, oxidative stress, lipid peroxidation, and steatohepatitis 1.
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Hepatic fat accumulation associated with insulin resistance, obesity, type 2 diabetes mellitus, and dyslipidemia, progressing from steatosis to steatohepatitis (MASH) and fibrosis 1.
- Cholestatic and Autoimmune Disorders: Primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis, characterized by immune-mediated destruction of intrahepatic or extrahepatic bile ducts and hepatocytes 1.
- Genetic and Inborn Errors of Metabolism: Hereditary hemochromatosis (iron overload), Wilson disease (copper accumulation), alpha-1 antitrypsin deficiency, and cystic fibrosis-associated liver disease 1.
- Vascular and Cardiac Factors: Chronic right-sided heart failure, constrictive pericarditis, and hepatic venous outflow obstruction (Budd-Chiari syndrome) causing chronic passive congestion and centrilobular ischemic necrosis 1.
Pathophysiology
The pathophysiological progression toward an elevated Child-Pugh score begins with sustained parenchymal injury, which triggers chronic activation of hepatic stellate cells within the Space of Disse 1. Upon activation, these cells transdifferentiate into proliferative, fibrogenic myofibroblasts that secrete excessive extracellular matrix proteins, predominantly fibrillar collagens type I and III 1. Concurrently, fenestrations of the hepatic sinusoidal endothelial cells are lost—a process termed sinusoidal capillarization—which severely impairs the bidirectional exchange of nutrients, proteins, and metabolites between hepatocytes and sinusoidal blood 1.
As fibrous septa bridge portal tracts and central veins, normal hepatic architecture is replaced by regenerative nodules, dramatically increasing intrahepatic vascular resistance 1. This fixed structural distortion, compounded by dynamic intrahepatic vasoconstriction mediated by endothelin-1 and a deficiency in vasodilatory nitric oxide, drives portal hypertension 1. Elevated sinusoidal and portal pressures force fluid into the peritoneal cavity (ascites) and promote portosystemic collateral formation, including gastroesophageal varices 1. Simultaneously, parenchymal destruction reduces the functional hepatocyte mass, impairing the synthesis of vital proteins such as albumin and coagulation factors (factors II, V, VII, IX, and X), while reducing the liver's capacity to metabolize endogenous toxins like ammonia, culminating in coagulopathy, jaundice, and hepatic encephalopathy 1,2.
Clinical Presentation & Classic Clinical Signs
- History & Cardinal Symptoms: Patients frequently present with progressive abdominal distension due to ascites, generalized fatigue, muscle wasting, pruritus from cholestasis, right upper quadrant discomfort, and cognitive slowing, forgetfulness, or inverted sleep-wake cycles indicative of hepatic encephalopathy 1.
- Physical Examination & Named Clinical Signs:
- Cutaneous Findings: Spider angiomas (telangiectasias distributed over the upper trunk, neck, and face), palmar erythema, and paper-money skin on the upper chest 1.
- Endocrine Changes: Gynecomastia, testicular atrophy, and loss of chest or axillary hair in male patients due to altered sex hormone metabolism 1.
- Abdominal Inspection & Palpation: Dilated periumbilical collateral veins (caput medusae), shifting dullness and fluid wave indicative of ascites, and either hepatomegaly (in early or steatotic disease) or a shrunken, nodular left lobe (in advanced cirrhosis) 1.
- Neurological Signs: Asterixis (coarse flapping tremor observed when the patient extends the wrists with fingers spread), constructional apraxia, and fetor hepaticus (musty, sweet breath odor caused by mercaptans) 1.
Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)
| Diagnostic Modality / Test | Expected Clinical & Radiological / Laboratory Finding |
|---|---|
| Gold-Standard Investigation | Percutaneous or transjugular liver biopsy demonstrating bridging fibrosis (Metavir stage F4 or Ishak stage 5–6) with architectural disruption and regenerative nodules, alongside HVPG measurement exceeding 5 mmHg (clinically significant portal hypertension at >10 mmHg). |
| Laboratory Panel | Elevated total serum bilirubin, prolonged prothrombin time / elevated INR, decreased serum albumin, thrombocytopenia (secondary to hypersplenism and reduced thrombopoietin production), hyponatremia, and elevated serum creatinine if renal impairment is present. |
| Imaging / Radiology (X-ray, US, CT, MRI) | Abdominal ultrasound demonstrating a nodular liver contour, blunt liver edges, caudate lobe hypertrophy, splenomegaly, recanalized umbilical vein, and free intraperitoneal fluid; Doppler evaluation confirms altered portal vein flow velocity and direction. |
| ECG / Histopathology / Procedural | Electrocardiogram may exhibit prolonged QTc intervals (cirrhotic cardiomyopathy); paracentesis demonstrates a serum-ascites albumin gradient (SAAG) ≥1.1 g/dL, confirming portal hypertension. |
Staging, Classification & Clinical Scoring Systems
| Criterion / Stage / Score Component | Clinical Threshold, Points & Management Implication |
|---|---|
| Encephalopathy Grade | None = 1 point; Grade 1–2 (or controlled with medication) = 2 points; Grade 3–4 (or refractory) = 3 points. Reflects nitrogenous waste accumulation and blood-brain barrier dysfunction 1. |
| Ascites Severity | None = 1 point; Mild (responsive to diuretics) = 2 points; Moderate to Severe (refractory or poorly controlled) = 3 points, resulting from hydrostatic pressure and neurohormonal activation 1. |
| Total Bilirubin (mg/dL) | <2.0 = 1 point; 2.0–3.0 = 2 points; >3.0 = 3 points (Note: For primary biliary cholangitis/cholestasis, modified thresholds apply: 4.0–10.0 = 2 points, >10.0 = 3 points) 1. |
| Serum Albumin (g/dL) | >3.5 = 1 point; 2.8–3.5 = 2 points; <2.8 = 3 points. Quantifies hepatic synthetic impairment 1. |
| Prothrombin Time (Seconds Over Control) or INR | PT prolongation 1–4 sec (INR <1.7) = 1 point; PT prolongation 4–6 sec (INR 1.7–2.3) = 2 points; PT prolongation >6 sec (INR >2.3) = 3 points 1. |
| Child-Pugh Class Summary | Class A (Score 5–6): Well-compensated disease, excellent perioperative survival; Class B (Score 7–9): Significant functional compromise, moderate risk; Class C (Score 10–15): Decompensated disease, high mortality and transplant evaluation threshold 1,2,3. |
Differential Diagnosis
| Differential Condition | Distinguishing Clinical, Biochemical & Imaging Features |
|---|---|
| Non-Cirrhotic Portal Hypertension | Portal hypertension, splenomegaly, and varices present, but liver synthetic function (albumin, INR, bilirubin) remains preserved, yielding a normal Child-Pugh score (Class A) 1. |
| Fulminant Hepatic Failure (Acute Liver Failure) | Rapid onset of severe liver injury and encephalopathy within weeks in a patient without pre-existing liver disease; coagulopathy and jaundice are profound, but architectural cirrhosis is absent on histology and imaging 1. |
| Constrictive Pericarditis / Right Heart Failure | Causes hepatomegaly, ascites, and elevated bilirubin, but serum albumin and synthetic parameters are typically preserved unless secondary cardiac cirrhosis has developed 1. |
| Peritoneal Carcinomatosis | Presents with massive ascites and abdominal distension, but the serum-ascites albumin gradient (SAAG) is typically <1.1 g/dL, liver enzymes and synthetic function are normal, and cytology reveals malignant cells 1. |
Management & Treatment Protocol
- Initial Stabilization & Resuscitation: Assess airway, breathing, and circulation. Correct severe coagulopathy and thrombocytopenia prior to invasive procedures using fresh frozen plasma, cryoprecipitate, or platelet transfusions only if bleeding is active or procedural risk is high 1. Avoid nephrotoxic agents and aggressive diuresis that can precipitate hepatorenal syndrome 1.
- First-Line Medical / Pharmacological Therapy (with exact adult dosing):
- Ascites Management: Implement dietary sodium restriction (<2 g/day or 88 mmol/day). Administer combination diuretic therapy with spironolactone (100 mg orally once daily, titrated up to 400 mg daily) and furosemide (40 mg orally once daily, titrated up to 160 mg daily) maintaining a strict weight loss target of 0.5 kg/day (or 1 kg/day if peripheral edema is present) 1.
- Hepatic Encephalopathy: Administer lactulose syrup at an initial adult dose of 20 to 30 mL (15–22 g) orally every 1–2 hours until soft bowel movements are achieved, subsequently adjusting to maintain 2 to 3 soft stools daily. Add rifaximin (550 mg orally twice daily) as secondary prophylaxis for recurrent episodes 1.
- Variceal Bleeding Prophylaxis: Initiate non-selective beta-blockers (e.g., carvedilol 6.25 mg orally once to twice daily, or propranolol 20–40 mg orally twice daily) for medium-to-large esophageal varices 1.
- Surgical / Interventional Indications: Large-volume therapeutic paracentesis (removing >5 liters) accompanied by intravenous albumin infusion (6–8 g of 25% albumin per liter of fluid removed) for tense ascites; endoscopic band ligation (EBL) for bleeding varices; Transjugular Intrahepatic Portosystemic Shunt (TIPS) placement for refractory ascites or recurrent variceal hemorrhage; and referral for orthotopic liver transplantation for patients with a Child-Pugh score ≥7 (Class B or C) 1,2,3.
Complications & Prognosis
- Key acute and chronic complications include acute variceal hemorrhage, spontaneous bacterial peritonitis (SBP), hepatic encephalopathy, hepatorenal syndrome (HRS), portopulmonary hypertension, and hepatocellular carcinoma (HCC) transformation 1,3.
- Prognosis is directly correlated with the Child-Pugh class: Child-Pugh Class A is associated with a 1-year survival rate exceeding 85–100%, whereas Class C indicates advanced hepatic failure with 1-year survival dropping to 35–45%, mandating urgent evaluation for liver transplantation and multidisciplinary specialized hepatology care 1,2,3.